indicated that SND1 is overexpressed in various cancers, including breast, prostate, colorectal cancer and malignant gliomas, regulating multiple mechanisms of gene expression such as transcriptional activation, RNA stability and RNA interference. This evidence concerns the gene SND1 and colorectal cancer.